These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 18632973)

  • 1. Binding of equine infectious anemia virus to the equine lentivirus receptor-1 is mediated by complex discontinuous sequences in the viral envelope gp90 protein.
    Sun C; Zhang B; Jin J; Montelaro RC
    J Gen Virol; 2008 Aug; 89(Pt 8):2011-2019. PubMed ID: 18632973
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mapping of equine lentivirus receptor 1 residues critical for equine infectious anemia virus envelope binding.
    Zhang B; Sun C; Jin S; Cascio M; Montelaro RC
    J Virol; 2008 Feb; 82(3):1204-13. PubMed ID: 18032504
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A tumor necrosis factor receptor family protein serves as a cellular receptor for the macrophage-tropic equine lentivirus.
    Zhang B; Jin S; Jin J; Li F; Montelaro RC
    Proc Natl Acad Sci U S A; 2005 Jul; 102(28):9918-23. PubMed ID: 15985554
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Equine infectious anemia virus envelope evolution in vivo during persistent infection progressively increases resistance to in vitro serum antibody neutralization as a dominant phenotype.
    Howe L; Leroux C; Issel CJ; Montelaro RC
    J Virol; 2002 Nov; 76(21):10588-97. PubMed ID: 12368301
    [TBL] [Abstract][Full Text] [Related]  

  • 5. An equine infectious anemia virus variant superinfects cells through novel receptor interactions.
    Brindley MA; Zhang B; Montelaro RC; Maury W
    J Virol; 2008 Oct; 82(19):9425-32. PubMed ID: 18667522
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Localization of conserved and variable antigenic domains of equine infectious anemia virus envelope glycoproteins using recombinant env-encoded protein fragments produced in Escherichia coli.
    Payne SL; Rushlow K; Dhruva BR; Issel CJ; Montelaro RC
    Virology; 1989 Oct; 172(2):609-15. PubMed ID: 2552661
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Structural insight into equine lentivirus receptor 1.
    Qian L; Han X; Liu X
    Protein Sci; 2015 May; 24(5):633-42. PubMed ID: 25559821
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mice transgenic for equine cyclin T1 and ELR1 are susceptible to equine infectious anemia virus infection.
    Du C; Ma J; Liu Q; Li YF; He XJ; Lin YZ; Wang XF; Meng QW; Wang X; Zhou JH
    Retrovirology; 2015 Apr; 12():36. PubMed ID: 25928027
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A conservative domain shared by HIV gp120 and EIAV gp90: implications for HIV vaccine design.
    Li H; Zhang X; Fan X; Shen T; Tong X; Shen R; Shao Y
    AIDS Res Hum Retroviruses; 2005 Dec; 21(12):1057-9. PubMed ID: 16379610
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nonsynonymous changes of equine lentivirus receptor-1 (ELR1) gene in amino acids involved in the interaction with equine infectious anemia virus (EIAV).
    Corbi-Botto CM; Sadaba SA; Zappa ME; Peral-García P; Díaz S
    Res Vet Sci; 2017 Jun; 112():185-191. PubMed ID: 28500993
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Novel and dynamic evolution of equine infectious anemia virus genomic quasispecies associated with sequential disease cycles in an experimentally infected pony.
    Leroux C; Issel CJ; Montelaro RC
    J Virol; 1997 Dec; 71(12):9627-39. PubMed ID: 9371627
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Amino acid mutations in the env gp90 protein that modify N-linked glycosylation of the Chinese EIAV vaccine strain enhance resistance to neutralizing antibodies.
    Han X; Zou J; Wang X; Guo W; Huo G; Shen R; Xiang W
    Viral Immunol; 2010 Oct; 23(5):531-9. PubMed ID: 20883167
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The soluble form of the EIAV receptor encoded by an alternative splicing variant inhibits EIAV infection of target cells.
    Lin YZ; Yang F; Zhang SQ; Sun LK; Wang XF; Du C; Zhou JH
    PLoS One; 2013; 8(11):e79299. PubMed ID: 24278125
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Equine infectious anemia virus genomic evolution in progressor and nonprogressor ponies.
    Leroux C; Craigo JK; Issel CJ; Montelaro RC
    J Virol; 2001 May; 75(10):4570-83. PubMed ID: 11312327
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antigenic analysis of equine infectious anemia virus (EIAV) variants by using monoclonal antibodies: epitopes of glycoprotein gp90 of EIAV stimulate neutralizing antibodies.
    Hussain KA; Issel CJ; Schnorr KL; Rwambo PM; Montelaro RC
    J Virol; 1987 Oct; 61(10):2956-61. PubMed ID: 2442410
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Detailed mapping of the antigenicity of the surface unit glycoprotein of equine infectious anemia virus by using synthetic peptide strategies.
    Ball JM; Rushlow KE; Issel CJ; Montelaro RC
    J Virol; 1992 Feb; 66(2):732-42. PubMed ID: 1370556
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Epitope shifting of gp90-specific cellular immune responses in EIAV-infected ponies.
    Liu C; Cook SJ; Craigo JK; Cook FR; Issel CJ; Montelaro RC; Horohov DW
    Vet Immunol Immunopathol; 2014 Oct; 161(3-4):161-9. PubMed ID: 25176006
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Unique evolution characteristics of the envelope protein of EIAV(LN₄₀), a virulent strain of equine infectious anemia virus.
    Wang X; Wang S; Lin Y; Jiang C; Ma J; Zhao L; Lv X; Wang F; Shen R; Zhou J
    Virus Genes; 2011 Apr; 42(2):220-8. PubMed ID: 21369830
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Insertions, duplications and substitutions in restricted gp90 regions of equine infectious anaemia virus during febrile episodes in an experimentally infected horse.
    Zheng YH; Nakaya T; Sentsui H; Kameoka M; Kishi M; Hagiwara K; Takahashi H; Kono Y; Ikuta K
    J Gen Virol; 1997 Apr; 78 ( Pt 4)():807-20. PubMed ID: 9129653
    [TBL] [Abstract][Full Text] [Related]  

  • 20. EIAV genomic organization: further characterization by sequencing of purified glycoproteins and cDNA.
    Ball JM; Payne SL; Issel CJ; Montelaro RC
    Virology; 1988 Aug; 165(2):601-5. PubMed ID: 2841805
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.